such problems the students were top (23% failures), house officers second (35%), and, surprisingly, nurses bottom (70%).8 Bridges and Goldberg in their paper in this week's BMJ speak of neurologists, but it is not clear whether they are referring to the consultants or to the registrars, and it will be impossible to decide who recognised or failed to recognise a psychiatric component in the patient's illness.
In most hospitals, however, the most sensitive and comprehensive history is probably that taken by the registrar or his equivalent. How good it will be will depend on his experience and particular interest. An even better history would probably be obtained by the consultantprovided that he had adequate time to do this. Unfortunately, he seldom has-unlike the consultant physician or neurologist in private practice, who will set aside an hour to take a full history, examine the patient, and explain to him or her how he plans to proceed. This will be done in private, undisturbed by bleeps or other interruptions. If such an approach were possible with health service patients, and it should be, the psychiatric component of acute medical illnesses would be recognised more frequently. Expenditure on the National Health Service in Britain is less than in other developed countries. We do not have enough consultants in the acute medical and surgical specialties to allow them to devote sufficient time to each patient. Doctors in training rarely have sufficient time and many lack the experience to recognise psychiatric problems in their patients. Furthermore, facilities for a private, unhurried, and undisturbed interview are seldom available. The fact that the service is as good as it is is a tribute to the dedication of those who work in it. If the country could afford it, it could be very much better. 
Postmyocardial infarction syndrome
In the postmyocardial infarction syndrome of Dressler, fever and pleuropericardial pain occur after a coronary occlusion.' In nearly all respects the syndrome is similar to the postcardiotomy syndrome which affects patients recovering from heart surgery.2 A pericardial friction rub may be heard in most patients, and pericardial and pleural effusions are common. The syndrome is rarely seen earlier than the second week after myocardial infarction and its peak incidence is during the first three months.3 This is a self limiting condition: the symptoms do not last longer than four to six weeks, but they tend to recur-sometimes as late as two years after the initial episode. 4 Careful and prolonged follow up of many patients is required to determine the incidence of the postmyocardial infarction syndrome. The logistical problem is compounded by the absence of a specific diagnostic marker. There are no simple diagnostic laboratory tests for the syndrome, though the erythrocyte sedimentation rate and the peripheral white cell count are usually raised. Specific serological abnormalities have been sought, based on the widely held view that the syndrome is a hypersensitivity reaction to autologous heart tissue with altered antigenicity as a result of ischaemia. Viral infection and blood in the pericardium have also been invoked as possible causes of the hypersensitivity. '°Certainly the characteristic latency period, the polyserositis, and the favourable response to immunosuppressive drugs are circumstantial support for an autoimmune aetiology. Heart reactive antibodies are frequently detected after myocardial infarction but the finding is nonspecific (particularly with a weakly positive result) and does not necessarily herald the development of the postmyocardial infarction syndrome." '-On the other hand, a strongly positive test result appears to be more specific,'3 '5 and Williams et al have proposed this as a potentially useful diagnostic marker.'5 Nevertheless, such serological testing requires technical and methodological skills that are likely to confine its application to specialist centres. 16 17 The diagnostic criteria chosen by Welin et al are satisfactory for most cases of postmyocardial infarction syndrome.5 Radiographic and ultrasound studies provide additional information on the presence of pleural and pericardial effusions. Further investigation is necessary, however, to exclude the possibility of extension or recurrence of myocardial infarction, pulmonary embolism, and congestive heart failure, all ofwhich are frequent in the weeks after infarction, and all of which have a poor prognosis. By contrast, the postmyocardial infarction syndrome is usually a benign illness which does not affect cumulative mortality.5 The only potentially lethal complication is cardiac tamponade,'8 which is rare and tends to occur in patients having anticoagulant treatment, who are at risk of pericardial haemorrhage.3 Anticoagulants should not, therefore, be prescribed for patients with this syndrome.
Evaluation of treatment is difficult because the postmyocardial infarction syndrome is self limiting. Simple antiinflammatory analgesics such as aspirin will usually control symptoms but do not appear to influence the course of the illness. In severe cases treatment with corticosteroids often results in a dramatic response with resolution of fever and relief of pain within 24 hours, although the condition tends to relapse after stopping treatment. 4 Whether this is a specific adverse effect of treatment or a characteristic of the illness is not clear. Gradual withdrawal of corticosteroids after a short course of treatment is probably a sensible precaution. If corticosteroids are contraindicated or produce unwanted side effects, other immunosuppressive agents may be effective. ' 
Drugs and intravenous fluids
In 1976 the Department of Health issued a circular (HC76(9)) commending to health authorities the report of a working party on adding drugs to intravenous infusion fluids.' To those who are not concerned with the emergency treatment of patients this may appear a trivial and even slightly abstruse problem-but this impression would not be correct. It was then, and continues to be, a matter of concern to many doctors, nurses, pharmacists, and financial administrators-and one in which scant progress has been made in the past eight years.
Drugs are added to between a third and almost a half of all intravenous infusions set up in hospital wards. The drugs most frequently given in this way are potassium, antibiotics, and antiarrhythmics. In addition, many drugs are given intermittently intravenously through the giving set of the infusion. Doctors prescribing drugs to be given in this way do not always appreciate the potential problems-for example, asepsis cannot always be maintained and the drug may interact with the intravenous fluid, with reduced drug efficacy or increased drug toxicity. There is even a risk that the drug may not get to the patient at all (p 678).
Several factors contribute to the unsatisfactory administration of drugs by the intravenous route, as the 1976 circular points out. Firstly, most of the information about the administration of drugs and possible drug interactions is published in the pharmaceutical journals. Since two thirds of infusions are set up after 5 pm-and pharmacists usually work a standard eight hour day-the doctor may not have easy access to the facts that he needs. Secondly, the responsibility for adding drugs to the infusion fluids frequently rests with the nurse. Too often her authority, responsibility, and training are either not defined or are inadequate and local policies and standards of competence may vary widely. Thirdly, the safety of intravenous drug treatment may be prejudiced because prescriptions are inaccurate or the instructions are not given clearly, or both.
At a recent meeting in Cambridge members of the medical, nursing, and pharmaceutical professions discussed how far these difficulties had been overcome. Sadly, few changes appear to have taken place, and none of the professions emerge with great credit. Thus few medical schools include specific undergraduate teaching on the intravenous administration of drugs. Another useful measure would be to draw up a shortlist of rules to give to all doctors likely to administer drugs intravenously, so that the common problems could be recognised and avoided. For example, drugs should not be mixed in a syringe unless the data sheet, or other reliable source of information, indicates that this is permissible; drugs should be added to infusions only immediately before use; no more than one drug should be added to a minipack and no more than two to an infusion pack (again checking that they are compatible both with each other and with the infusion fluid). A new book, Guide to Parenteral Administration ofDrugs, provides a good source of information, for it outlines the principles underlying the intravenous administration of drugs and gives details of most of the drugs that are given parenterally.2 It also gives information about the route of administration and which drug and fluid combinations are incompatible.
New house physicians and surgeons often regard the intravenous line as just a convenient route for the administration of drugs. Their attitude might change, however, if part of the introductory course, which most hospitals offer their new resident staff, was devoted to a discussion of the difficulties that may arise when giving drugs by this route. Teaching might be taken by a clinician with a special interest (perhaps an anaesthetist) together with a pharmacist or a nurse, or both. These sessions should build on the basic information given to undergraduates.
Possibly it is the pharmacists who should be providing a clear lead, and in some hospitals this may be happening. In most hospitals, however, pharmacists do not provide a 24 hour service for making up infusions, or even for giving advice, and in this respect the role of the pharmacist (like that of the doctor) has altered little since 1976. Nurses are the one group who have attempted to make changes, and-given that they usually administer this form of treatment-have set about providing full specialist training for some of their staff. Unfortunately, these efforts have been sporadic and no national standards have been agreed; furthermore, nursing education on all aspects of therapeutics remains limited. This will have to change if the responsibility for intravenous treatment is to pass into their hands-a move which is not only possible but probably desirable, given the medical profession's longstanding reluctance to take the problem seriously.
Since 1976 drug and therapeutic committees have been set up to coordinate, improve, and simplify drug treatment in hospital. Yet few of these committees appear to have considered the problem of drugs and intravenous therapy, and where overall authority lies for this method of drug treatment is still not clear. Technical advances have occurred, however, and the equipment used to administer
